🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
The overall aim of the study is to corroborate that a schedule consisting o...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00255047
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
This study is designed to assess the immunogenicity and safety of DTaP vacc...
Status
Completed
Location
Investigational site
Start Date
2014-04
Trial ID
NCT02118961
Primary Objective: To describe the persistence of Hep B antibodies (Ab) at...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02610348
Primary Objectives: 1. To present the safety profile after a 5th dose of D...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00258895
Treatments Being Tested
The aim of the study is to assess the persistence of anti-Hep B antibody at...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02697474
Treatments Being Tested